STIM

#3505
Neuronetics, Inc. - Common Stock
1.5 4 USD
-1.28%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
1.54
1.54
Range Annuel
0.80
4.82
Changement quotidien
-1.28%
Changement Mensuel
-9.41%
Evolution sur 6 mois
+3.36%
Changement Annuel
-60.71%
Clôture Précédente
1.5 6
Open
1.5 4
Low
1.5 4
High
1.5 4
Volume
33
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 107.17 M
  • Employee 658
  • Founded 2003
  • CEO N/A
  • Website www.neurostar.com
  • Headquarter Delaware, United States
  • FIGI BBG000QX36J1
  • Industry Diagnostic et Recherche
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.34
ratio cours/chiffre d'affaires
0.65

Neuronetics, Inc. - Common Stock

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device." They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head.

Nouvelles